KAISER Integrates DTx Into the Behavioral Health Treatment Paradigm at No Extra Cost After a Clinician Referral
Since the beginning of the COVID-19 pandemic, cases of depression and anxiety have more than tripled, increasing the unmet need in behavioral health. KAISER PERMANENTE has started offering integrated DTx to their patients in response to challenges associated with COVID-19, facilitating access to 6 different applications. This move, by one of the largest IDNs in the USA, aims to address the current mental health crisis and to continue delivering positive healthcare outcomes.
In this infographic, CBPartners offers key insights into KAISER’s approach for improving behavioral health outcomes with DTx, and explains why their approach to evidence generation is leading the way forward in this field.
Read the infographic here.
If you are interested in reading more about the digital therapeutics landscape, read related posts in the expertise team’s thought leadership channel.